Affimed Nv Stock Fundamentals
| AFMD Stock | USD 0.89 0.01 1.11% |
Affimed NV fundamentals help investors to digest information that contributes to Affimed NV's financial success or failures. It also enables traders to predict the movement of Affimed Stock. The fundamental analysis module provides a way to measure Affimed NV's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Affimed NV stock.
At present, Affimed NV's Interest Expense is projected to decrease significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 29.8 M, whereas EBIT is projected to grow to (89 M).
Affimed | Select Account or Indicator |
Affimed NV Company Shares Outstanding Analysis
Affimed NV's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Affimed NV Shares Outstanding | 16.39 M |
Most of Affimed NV's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Affimed NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Affimed Shares Outstanding Historical Pattern
Today, most investors in Affimed NV Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Affimed NV's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Affimed NV shares outstanding as a starting point in their analysis.
Affimed NV Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Affimed Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
At present, Affimed NV's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting.
Based on the latest financial disclosure, Affimed NV has 16.39 M of shares currently outstending. This is 90.92% lower than that of the Biotechnology sector and 84.66% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 97.13% higher than that of the company.
Affimed NV Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Affimed NV's current stock value. Our valuation model uses many indicators to compare Affimed NV value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Affimed NV competition to find correlations between indicators driving Affimed NV's intrinsic value. More Info.Affimed NV is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Affimed NV's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Affimed NV by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Affimed Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Affimed NV's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Affimed NV could also be used in its relative valuation, which is a method of valuing Affimed NV by comparing valuation metrics of similar companies.Affimed NV is currently under evaluation in shares outstanding category among its peers.
Affimed NV Current Valuation Drivers
We derive many important indicators used in calculating different scores of Affimed NV from analyzing Affimed NV's financial statements. These drivers represent accounts that assess Affimed NV's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Affimed NV's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 397.5M | 580.1M | 164.9M | 84.5M | 76.0M | 148.7M | |
| Enterprise Value | 251.9M | 401.2M | (7.2M) | 65.3M | 58.8M | 93.1M |
Affimed Fundamentals
| Return On Equity | -1.49 | ||||
| Return On Asset | -0.49 | ||||
| Operating Margin | (87.09) % | ||||
| Current Valuation | 1.33 M | ||||
| Shares Outstanding | 16.39 M | ||||
| Shares Owned By Insiders | 6.00 % | ||||
| Shares Owned By Institutions | 23.82 % | ||||
| Number Of Shares Shorted | 702.39 K | ||||
| Price To Earning | (2.04) X | ||||
| Price To Book | 0.77 X | ||||
| Price To Sales | 2.61 X | ||||
| Revenue | 8.28 M | ||||
| Gross Profit | 5.64 M | ||||
| EBITDA | (102.38 M) | ||||
| Net Income | (105.94 M) | ||||
| Cash And Equivalents | 237.23 M | ||||
| Cash Per Share | 1.59 X | ||||
| Total Debt | 19.35 M | ||||
| Debt To Equity | 0.1 % | ||||
| Current Ratio | 4.90 X | ||||
| Book Value Per Share | 1.05 X | ||||
| Cash Flow From Operations | (110.27 M) | ||||
| Short Ratio | 7.47 X | ||||
| Earnings Per Share | (4.98) X | ||||
| Target Price | 13.89 | ||||
| Number Of Employees | 76 | ||||
| Beta | 2.22 | ||||
| Market Capitalization | 14.7 M | ||||
| Total Asset | 97.16 M | ||||
| Retained Earnings | (536.13 M) | ||||
| Working Capital | 58.28 M | ||||
| Current Asset | 78.33 M | ||||
| Current Liabilities | 8.94 M | ||||
| Net Asset | 97.16 M |
About Affimed NV Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Affimed NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Affimed NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Affimed NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 711.9 K | 676.3 K | |
| Total Revenue | 9.5 M | 17.3 M | |
| Cost Of Revenue | 1.8 M | 1.1 M | |
| Stock Based Compensation To Revenue | 1.17 | 1.22 | |
| Sales General And Administrative To Revenue | 3.43 | 3.60 | |
| Research And Ddevelopement To Revenue | 10.33 | 10.84 | |
| Capex To Revenue | 0.41 | 0.43 | |
| Revenue Per Share | 0.50 | 0.47 | |
| Ebit Per Revenue | (11.60) | (11.02) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Affimed NV is a strong investment it is important to analyze Affimed NV's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Affimed NV's future performance. For an informed investment choice regarding Affimed Stock, refer to the following important reports:Check out Affimed NV Piotroski F Score and Affimed NV Altman Z Score analysis. For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Affimed NV. If investors know Affimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Affimed NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.98) | Revenue Per Share | Quarterly Revenue Growth (0.92) | Return On Assets | Return On Equity |
The market value of Affimed NV is measured differently than its book value, which is the value of Affimed that is recorded on the company's balance sheet. Investors also form their own opinion of Affimed NV's value that differs from its market value or its book value, called intrinsic value, which is Affimed NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Affimed NV's market value can be influenced by many factors that don't directly affect Affimed NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Affimed NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Affimed NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Affimed NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.